F. Pouillot, M. Chomton, and H. Blois, ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.3568-75, 2012.
DOI : 10.1128/AAC.06330-11

B. Chan, M. Sistrom, and J. Wertz, Phage selection restores antibiotic sensitivity in MDR Pseudomonas aeruginosa, Scientific Reports, vol.13, issue.1, p.26717, 2016.
DOI : 10.1093/bioinformatics/btl446

URL : http://www.nature.com/articles/srep26717.pdf

A. Bruttin and H. Brussow, Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage Therapy, Antimicrobial Agents and Chemotherapy, vol.49, issue.7, pp.2874-2882, 2005.
DOI : 10.1128/AAC.49.7.2874-2878.2005

URL : http://aac.asm.org/content/49/7/2874.full.pdf

S. Mccallin, A. Sarker, S. Barretto, and C. , Safety analysis of a Russian phage cocktail: From MetaGenomic analysis to oral application in healthy human subjects, Virology, vol.443, issue.2, pp.187-96, 2013.
DOI : 10.1016/j.virol.2013.05.022

R. Miedzybrodzki, J. Borysowski, and B. Weber-dabrowska, Clinical Aspects of Phage Therapy, Adv Virus Res, vol.83, pp.73-121, 2012.
DOI : 10.1016/B978-0-12-394438-2.00003-7

P. Miernikiewicz, K. Dabrowska, and A. Piotrowicz, T4 Phage and Its Head Surface Proteins Do Not Stimulate Inflammatory Mediator Production, PLoS ONE, vol.222, issue.1, p.71036, 2013.
DOI : 10.1371/journal.pone.0071036.t004

URL : https://doi.org/10.1371/journal.pone.0071036

K. Dabrowska, P. Miernikiewicz, and A. Piotrowicz, Immunogenicity Studies of Proteins Forming the T4 Phage Head Surface, Journal of Virology, vol.88, issue.21, pp.12551-12558, 2014.
DOI : 10.1128/JVI.02043-14

H. Ochs, R. Buckley, and R. Kobayashi, Antibody responses to bacteriophage phi X174 in patients with adenosine deaminase deficiency, Blood, vol.80, pp.1163-71, 1992.

M. Zaczek, M. Lusiak-szelachowska, and E. Jonczyk-matysiak, Antibody production in response to staphylococcal MS-1 phage cocktail in patients undergoing phage therapy, Front Microbiol, vol.7, p.1681, 2016.

H. Ando, S. Lemire, D. Pires, and T. Lu, Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing, Cell Systems, vol.1, issue.3, pp.187-96, 2015.
DOI : 10.1016/j.cels.2015.08.013

URL : https://doi.org/10.1016/j.cels.2015.08.013

E. Barbu, K. Cady, and B. Hubby, Phage Therapy in the Era of Synthetic Biology, Cold Spring Harbor Perspectives in Biology, vol.8, issue.10, 2016.
DOI : 10.1101/cshperspect.a023879

A. Wright, C. Hawkins, E. Anggard, and D. Harper, ; a preliminary report of efficacy, Clinical Otolaryngology, vol.8, issue.4, pp.349-57, 2009.
DOI : 10.3201/eid0809.020063

S. Sarker, S. Sultana, and G. Reuteler, Oral Phage Therapy of Acute Bacterial Diarrhea With Two Coliphage Preparations: A Randomized Trial in Children From Bangladesh, EBioMedicine, vol.4, pp.124-161, 2016.
DOI : 10.1016/j.ebiom.2015.12.023

M. Nicolas-chanoine, X. Bertrand, and J. Madec, Escherichia coli ST131, an Intriguing Clonal Group, Clinical Microbiology Reviews, vol.27, issue.3, pp.543-74, 2014.
DOI : 10.1128/CMR.00125-13

URL : https://hal.archives-ouvertes.fr/hal-01061609

N. Dufour, O. Clermont, L. Combe, and B. , clonal complex, Journal of Antimicrobial Chemotherapy, vol.2, issue.11, pp.3072-80, 2016.
DOI : 10.1093/jac/dks261

URL : https://hal.archives-ouvertes.fr/pasteur-01539016

M. Galtier, D. Sordi, L. Maura, and D. , Bacteriophages to reduce gut carriage of antibiotic resistant uropathogens with low impact on microbiota composition, Environmental Microbiology, vol.350, issue.7, pp.2237-2282, 2016.
DOI : 10.1126/science.aad6791

URL : https://hal.archives-ouvertes.fr/pasteur-01538960

M. Martinez-medina and L. Garcia-gil, pathogenicity, World Journal of Gastrointestinal Pathophysiology, vol.5, issue.3, pp.213-240, 2014.
DOI : 10.4291/wjgp.v5.i3.213

R. 2. Colomb-cotinat, M. Lacoste, J. Coignard, and B. , Morbidité et mortalité des infections à bactéries multi-résistantes aux antibiotiques en France en 2012, Étude Burden BMR. Saint-Maurice : Institut de Veille Sanitaire (InVS), 2015.

D. Center and . Control, Antibiotic resistance threats in the United States, Atlanta : CDC, 2013.

J. Carlet, The gut is the epicentre of antibiotic resistance, Antimicrobial Resistance and Infection Control, vol.1, issue.1, p.39, 2012.
DOI : 10.1093/cid/cir025

URL : https://aricjournal.biomedcentral.com/track/pdf/10.1186/2047-2994-1-39?site=aricjournal.biomedcentral.com

J. Carlet, L. Coz, and P. , Rapport du groupe de travail spécial pour la préservation des antibiotiques. Paris : Ministère des Affaires sociales, 2015.

F. Nobrega, A. Costa, L. Kluskens, and J. Azeredo, Revisiting phage therapy: new applications for old resources, Trends in Microbiology, vol.23, issue.4, pp.185-91, 2015.
DOI : 10.1016/j.tim.2015.01.006

S. Chibani-chennoufi, A. Bruttin, M. Dillmann, and H. Brussow, Phage-Host Interaction: an Ecological Perspective, Journal of Bacteriology, vol.186, issue.12, pp.3677-86, 2004.
DOI : 10.1128/JB.186.12.3677-3686.2004

URL : http://jb.asm.org/content/186/12/3677.full.pdf

F. Rohwer, Global Phage Diversity, Cell, vol.113, issue.2, p.141, 2003.
DOI : 10.1016/S0092-8674(03)00276-9

URL : https://doi.org/10.1016/s0092-8674(03)00276-9

A. Letarov and E. Kulikov, The bacteriophages in human- and animal body-associated microbial communities, Journal of Applied Microbiology, vol.4, issue.1, pp.1-13, 2009.
DOI : 10.1016/S1383-5718(00)00003-6

URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2672.2009.04143.x/pdf

C. Suttle, The significance of viruses to mortality in aquatic microbial communities, Microbial Ecology, vol.31, issue.2, pp.237-280, 1994.
DOI : 10.1007/BF00166813

B. Koskella and M. Brockhurst, Bacteria???phage coevolution as a driver of ecological and evolutionary processes in microbial communities, FEMS Microbiology Reviews, vol.80, issue.5, pp.916-947, 2014.
DOI : 10.1016/j.mib.2013.08.008

URL : https://academic.oup.com/femsre/article-pdf/38/5/916/18143202/38-5-916.pdf

F. Herelle, Sur un microbe invisible antagoniste des bacilles dysentériques, CR Acad Sci Paris, vol.165, pp.373-75, 1917.

S. Abedon, S. Kuhl, B. Blasdel, and E. Kutter, Phage treatment of human infections, Bacteriophage, vol.7, issue.2, pp.66-85, 2011.
DOI : 10.1016/S0041-1345(03)00525-6

URL : http://europepmc.org/articles/pmc3278644?pdf=render

D. Pires, H. Oliveira, and L. Melo, Bacteriophage-encoded depolymerases: their diversity and biotechnological applications, Applied Microbiology and Biotechnology, vol.28, issue.Pt 2, pp.2141-51, 2016.
DOI : 10.1007/s40259-013-0081-y

S. Abedon, Phage therapy of pulmonary infections, Bacteriophage, vol.129, issue.1, p.1020260, 2015.
DOI : 10.2217/FMB.15.28

URL : http://europepmc.org/articles/pmc4422798?pdf=render

E. Saussereau and L. Debarbieux, Bacteriophages in the Experimental Treatment of Pseudomonas aeruginosa Infections in Mice, Adv Virus Res, vol.83, pp.123-164, 2012.
DOI : 10.1016/B978-0-12-394438-2.00004-9

N. Dufour, L. Debarbieux, M. Fromentin, and J. Ricard, Treatment of Highly Virulent Extraintestinal Pathogenic Escherichia coli Pneumonia With Bacteriophages*, Critical Care Medicine, vol.43, issue.6, pp.190-198, 2015.
DOI : 10.1097/CCM.0000000000000968

URL : https://hal.archives-ouvertes.fr/pasteur-01539037

L. Debarbieux, D. Leduc, and D. Maura, Lung Infections, The Journal of Infectious Diseases, vol.201, issue.7, pp.1096-104, 2010.
DOI : 10.1086/651135

URL : https://hal.archives-ouvertes.fr/pasteur-01425464

N. Dufour, M. Henry, J. Ricard, and L. Debarbieux, Commentary: Morphologically Distinct Escherichia coli Bacteriophages Differ in Their Efficacy and Ability to Stimulate Cytokine Release In Vitro, Frontiers in Microbiology, vol.4, issue.437, p.1029, 2016.
DOI : 10.1371/journal.pone.0004944

URL : https://hal.archives-ouvertes.fr/pasteur-01539081

P. Speck and A. Smithyman, Safety and efficacy of phage therapy via the intravenous route, FEMS Microbiology Letters, vol.51, issue.3, 2016.
DOI : 10.1097/00007890-198202000-00008

URL : https://academic.oup.com/femsle/article-pdf/363/3/fnv242/10754110/fnv242.pdf

A. Comeau, F. Tetart, and S. Trojet, Phage-Antibiotic Synergy (PAS): ??-Lactam and Quinolone Antibiotics Stimulate Virulent Phage Growth, PLoS ONE, vol.50, issue.8, p.799, 2007.
DOI : 10.1371/journal.pone.0000799.g005

URL : https://hal.archives-ouvertes.fr/hal-00180524

J. Samson, A. Magadan, M. Sabri, and S. Moineau, Revenge of the phages: defeating bacterial defences, Nature Reviews Microbiology, vol.71, issue.10, pp.675-87, 2013.
DOI : 10.1016/0042-6822(76)90382-2

R. Dy, C. Richter, G. Salmond, and P. Fineran, Remarkable Mechanisms in Microbes to Resist Phage Infections, Annual Review of Virology, vol.1, issue.1, pp.307-338, 2014.
DOI : 10.1146/annurev-virology-031413-085500

A. Stern and R. Sorek, The phage-host arms race: Shaping the evolution of microbes, BioEssays, vol.34, issue.1, pp.43-51, 2011.
DOI : 10.1093/oxfordjournals.molbev.a004046

URL : http://europepmc.org/articles/pmc3274958?pdf=render

R. Capparelli, N. Nocerino, and M. Iannaccone, A Fresh Appraisal of Bacteriophage Therapy, The Journal of Infectious Diseases, vol.201, issue.1, pp.52-61, 2010.
DOI : 10.1086/648478

C. Hung, C. Kuo, and C. Wang, ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.55, issue.4, pp.1358-65, 2011.
DOI : 10.1128/AAC.01123-10

T. , Debarbieux Tarifs d'abonnement m/s, p.2017

, Abonnez-vous à médecine/sciences > Grâce à m/s, vivez en direct les progrès des sciences biologiques et médicales Bulletin d'abonnement page 450 dans ce